IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 218 filers reported holding IMMUNOGEN INC in Q2 2021. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $815,375 | +86.8% | 27,500 | 0.0% | 0.06% | +72.7% |
Q3 2023 | $436,424 | +68.2% | 27,500 | +100.0% | 0.03% | -15.4% |
Q2 2023 | $259,462 | -21.0% | 13,750 | -83.9% | 0.04% | -25.0% |
Q1 2023 | $328,512 | -22.5% | 85,550 | 0.0% | 0.05% | -25.7% |
Q4 2022 | $424,000 | +1.9% | 85,550 | -1.7% | 0.07% | -5.4% |
Q3 2022 | $416,000 | +6.4% | 87,000 | 0.0% | 0.07% | +5.7% |
Q2 2022 | $391,000 | -5.6% | 87,000 | 0.0% | 0.07% | +12.9% |
Q1 2022 | $414,000 | -35.7% | 87,000 | +0.2% | 0.06% | -33.3% |
Q4 2021 | $644,000 | +28.5% | 86,800 | -1.7% | 0.09% | +16.2% |
Q3 2021 | $501,000 | -13.9% | 88,300 | 0.0% | 0.08% | -13.0% |
Q2 2021 | $582,000 | -17.2% | 88,300 | +1.7% | 0.09% | -24.0% |
Q1 2021 | $703,000 | +24.9% | 86,800 | -0.6% | 0.12% | +13.1% |
Q4 2020 | $563,000 | +77.0% | 87,300 | -1.1% | 0.11% | +55.1% |
Q3 2020 | $318,000 | -21.7% | 88,300 | 0.0% | 0.07% | -27.4% |
Q2 2020 | $406,000 | +34.9% | 88,300 | 0.0% | 0.10% | +21.8% |
Q1 2020 | $301,000 | -24.8% | 88,300 | +12.8% | 0.08% | -6.0% |
Q4 2019 | $400,000 | +111.6% | 78,300 | 0.0% | 0.08% | +93.0% |
Q3 2019 | $189,000 | +11.2% | 78,300 | 0.0% | 0.04% | +10.3% |
Q2 2019 | $170,000 | -6.6% | 78,300 | +16.3% | 0.04% | -9.3% |
Q1 2019 | $182,000 | +31.9% | 67,300 | +133.7% | 0.04% | +16.2% |
Q4 2018 | $138,000 | -52.7% | 28,800 | -6.5% | 0.04% | -47.1% |
Q3 2018 | $292,000 | -2.7% | 30,800 | 0.0% | 0.07% | -13.6% |
Q2 2018 | $300,000 | -48.9% | 30,800 | -44.8% | 0.08% | -49.4% |
Q1 2018 | $587,000 | +57.8% | 55,800 | -3.8% | 0.16% | +56.9% |
Q4 2017 | $372,000 | -16.2% | 58,000 | 0.0% | 0.10% | -20.3% |
Q3 2017 | $444,000 | +7.8% | 58,000 | 0.0% | 0.13% | +3.2% |
Q2 2017 | $412,000 | +83.9% | 58,000 | 0.0% | 0.12% | +77.1% |
Q1 2017 | $224,000 | +128.6% | 58,000 | +20.8% | 0.07% | +118.8% |
Q4 2016 | $98,000 | +7.7% | 48,000 | +41.2% | 0.03% | +3.2% |
Q3 2016 | $91,000 | +56.9% | 34,000 | +81.8% | 0.03% | +55.0% |
Q2 2016 | $58,000 | -79.4% | 18,700 | -9.7% | 0.02% | -80.8% |
Q4 2015 | $281,000 | +4.5% | 20,700 | +10.7% | 0.10% | +5.1% |
Q3 2015 | $269,000 | 0.0% | 18,700 | 0.0% | 0.10% | 0.0% |
Q2 2015 | $269,000 | +61.1% | 18,700 | 0.0% | 0.10% | +62.3% |
Q1 2015 | $167,000 | – | 18,700 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
QVT Financial LP | 1,375,900 | $6,329,000 | 1.08% |
Redmile Group, LLC | 12,006,979 | $55,232,000 | 1.02% |
Birchview Capital, LP | 190,000 | $874,000 | 0.53% |
Fernwood Investment Management, LLC | 179,340 | $825,000 | 0.41% |
HealthCor Management, L.P. | 1,200,000 | $5,520,000 | 0.23% |
Grace Capital | 49,500 | $228,000 | 0.20% |
TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $479,000 | 0.19% |
Virtus ETF Advisers LLC | 79,795 | $367,000 | 0.17% |
PINNACLE ASSOCIATES LTD | 1,087,034 | $5,000,000 | 0.12% |
HUSSMAN STRATEGIC ADVISORS, INC. | 100,000 | $460,000 | 0.12% |